| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8545395 | Chemico-Biological Interactions | 2017 | 31 Pages |
Abstract
Our results suggest an alternative treatment regimen for this fatal cancer type which circumvents many of the traditional barriers. Using the metabolic defect in GBM thus warrants further (pre-) clinical evaluation.
Keywords
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Claudia Maletzki, Yvonne Rosche, Christin Riess, Aline Scholz, Doreen William, Carl Friedrich Classen, Bernd Kreikemeyer, Michael Linnebacher, Tomas Fiedler,